A study by Fox Chase Cancer Center researchers found that as many as 23% of cystic renal masses may carry high grade, or aggressive, disease.
Jeffrey M. Farma was appointed chair of surgery at Fox Chase Cancer Center.
Fox Chase study challenges assumptions about cystic renal masses
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Fox Chase Cancer Center received a gift of $10.8 million from the Estate of Concetta “Chet” Greenberg. This gift is the culmination of many years of support, bringing Greenberg’s total giving to nearly $20 million for pancreatic cancer research at Fox Chase.
Daniel M. Geynisman was named the editor-in-chief of JNCCN—Journal of the National Comprehensive Cancer Network.
Fox Chase Cancer Center has contributed two articles to the Cancer History Project, documenting the impact of Paul Grotzinger and Gerald “Jerry” Hanks.
In a phase I clinical trial led by UT Southwestern Medical Center, a short interfering RNA drug directed to tumor cells effectively disrupted HIF2α, a key driver of clear cell renal cell carcinoma.
Fox Chase Cancer Center opened its newly expanded Buckingham site, located in Furlong, PA.
